Source: Life Sciences. Unidade: FMRP
Subjects: ANTIDEPRESSIVOS, MÚSCULO ESQUELÉTICO, METABOLISMO DE PROTEÍNA, PROTEÍNAS DO TECIDO NERVOSO, TRANSDUÇÃO DE SINAL CELULAR
ABNT
ARCARO, Carlos Alberto et al. Phosphodiesterase 4 inhibition restrains muscle proteolysis in diabetic rats by activating PKA and EPAC/Akt effectors and inhibiting FoxO factors. Life Sciences, v. 278, p. 1-12, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.lfs.2021.119563. Acesso em: 30 ago. 2024.APA
Arcaro, C. A., Assis, R. P., Oliveira, J. O., Zanon, N. M., Paula-Gomes, S., Navegantes, L. C. C., et al. (2021). Phosphodiesterase 4 inhibition restrains muscle proteolysis in diabetic rats by activating PKA and EPAC/Akt effectors and inhibiting FoxO factors. Life Sciences, 278, 1-12. doi:10.1016/j.lfs.2021.119563NLM
Arcaro CA, Assis RP, Oliveira JO, Zanon NM, Paula-Gomes S, Navegantes LCC, Kettelhut I do C, Brunetti IL, Baviera AM. Phosphodiesterase 4 inhibition restrains muscle proteolysis in diabetic rats by activating PKA and EPAC/Akt effectors and inhibiting FoxO factors [Internet]. Life Sciences. 2021 ; 278 1-12.[citado 2024 ago. 30 ] Available from: https://doi.org/10.1016/j.lfs.2021.119563Vancouver
Arcaro CA, Assis RP, Oliveira JO, Zanon NM, Paula-Gomes S, Navegantes LCC, Kettelhut I do C, Brunetti IL, Baviera AM. Phosphodiesterase 4 inhibition restrains muscle proteolysis in diabetic rats by activating PKA and EPAC/Akt effectors and inhibiting FoxO factors [Internet]. Life Sciences. 2021 ; 278 1-12.[citado 2024 ago. 30 ] Available from: https://doi.org/10.1016/j.lfs.2021.119563